Quinagolide: Difference between revisions

	WikiDoc Resources for Quinagolide
Articles
Most recent articles on Quinagolide Most cited articles on Quinagolide Review articles on Quinagolide Articles on Quinagolide in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Quinagolide Images of Quinagolide Photos of Quinagolide Podcasts & MP3s on Quinagolide Videos on Quinagolide
Evidence Based Medicine
Cochrane Collaboration on Quinagolide Bandolier on Quinagolide TRIP on Quinagolide
Clinical Trials
Ongoing Trials on Quinagolide at Clinical Trials.gov Trial results on Quinagolide Clinical Trials on Quinagolide at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Quinagolide NICE Guidance on Quinagolide NHS PRODIGY Guidance FDA on Quinagolide CDC on Quinagolide
Books
Books on Quinagolide
News
Quinagolide in the news Be alerted to news on Quinagolide News trends on Quinagolide
Commentary
Blogs on Quinagolide
Definitions
Definitions of Quinagolide
Patient Resources / Community
Patient resources on Quinagolide Discussion groups on Quinagolide Patient Handouts on Quinagolide Directions to Hospitals Treating Quinagolide Risk calculators and risk factors for Quinagolide
Healthcare Provider Resources
Symptoms of Quinagolide Causes & Risk Factors for Quinagolide Diagnostic studies for Quinagolide Treatment of Quinagolide
Continuing Medical Education (CME)
CME Programs on Quinagolide
International
Quinagolide en Espanol Quinagolide en Francais
Business
Quinagolide in the Marketplace Patents on Quinagolide
Experimental / Informatics
List of terms related to Quinagolide

Quinagolide
Clinical data
AHFS/Drugs.com	International Drug Names
Routes of; administration	Oral
ATC code	G02CB04 (WHO) ;
Legal status
Legal status	In general: ℞ (Prescription only);
Identifiers
	IUPAC name N,N-diethyl-N'-[(3S,4aS,10aR)-6-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-3-yl]sulfamide;
CAS Number	87056-78-8 ;
PubChem CID	55645;
ChemSpider	2343034 ;
UNII	80Q9QWN15M;
KEGG	D07217 ;
ChEMBL	ChEMBL290962 ;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C20H33N3O3S
Molar mass	395.56 g/mol
	InChI InChI=1S/C20H33N3O3S/c1-4-10-22-14-17(21-27(25,26)23(5-2)6-3)11-16-12-18-15(13-19(16)22)8-7-9-20(18)24/h7-9,16-17,19,21,24H,4-6,10-14H2,1-3H3/t16-,17+,19-/m1/s1 ; Key:GDFGTRDCCWFXTG-ZIFCJYIRSA-N ;
(what is this?) (verify)

VisualWikitext

Latest revision as of 17:02, 20 August 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Quinagolide (Norprolac) is a selective, D₂ receptor agonist that is used for the treatment of elevated levels of prolactin.^[1]

References

↑ Antonella Di Sarno, Maria Luisa Landi, Paolo Marzullo, Carolina Di Somma, Rosario Pivonello, Gaetana Cerbone, Gaetano Lombardi, Annamaria Colao (July 2000). "The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas". Clinical Endocrinology. 53 (1): 53–60. doi:10.1046/j.1365-2265.2000.01016.x. PMID 10931080.

[1] Antonella Di Sarno, Maria Luisa Landi, Paolo Marzullo, Carolina Di Somma, Rosario Pivonello, Gaetana Cerbone, Gaetano Lombardi, Annamaria Colao (July 2000). "The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas". Clinical Endocrinology. 53 (1): 53–60. doi:10.1046/j.1365-2265.2000.01016.x. PMID 10931080.

[1]

@@ Line 42: / Line 42: @@
 }}
 __NOTOC__
 {{SI}}
 {{CMG}}
 ==Overview==
 '''Quinagolide''' ('''Norprolac''') is a [[binding selectivity|selective]], [[D2 receptor|D<sub>2</sub> receptor]] [[agonist]] that is used for the treatment of elevated levels of [[prolactin]].<ref>{{cite journal |title = The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas |author = Antonella Di Sarno, Maria Luisa Landi, Paolo Marzullo, Carolina Di Somma, Rosario Pivonello, Gaetana Cerbone, Gaetano Lombardi, Annamaria Colao |journal = Clinical Endocrinology |volume = 53 |issue = 1 |pages = 53–60 |date=July 2000 |doi = 10.1046/j.1365-2265.2000.01016.x |url = http://onlinelibrary.wiley.com/doi/10.1046/j.1365-2265.2000.01016.x/full |pmid=10931080}}</ref>
-== See also ==
-* [[Terguride]]
 == References ==
 {{Reflist|2}}
-{{Other gynecologicals}}
-{{Aphrodisiacs}}
-{{Dopaminergics}}
 [[Category:Tocolytics]]
 [[Category:Phenols]]
-[[Category:Benzoquinolines]]
 [[Category:Drug]]

Clinical data

AHFS/Drugs.com	International Drug Names
Routes of administration	Oral
ATC code	G02CB04 (WHO)
Legal status
Legal status	In general: ℞ (Prescription only)
Identifiers
IUPAC name N,N-diethyl-N'-[(3S,4aS,10aR)-6-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-3-yl]sulfamide
CAS Number	87056-78-8^N
PubChem CID	55645
ChemSpider	2343034^Y
UNII	80Q9QWN15M
KEGG	D07217^Y
ChEMBL	ChEMBL290962^Y
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₂₀H₃₃N₃O₃S
Molar mass	395.56 g/mol
InChI InChI=1S/C20H33N3O3S/c1-4-10-22-14-17(21-27(25,26)23(5-2)6-3)11-16-12-18-15(13-19(16)22)8-7-9-20(18)24/h7-9,16-17,19,21,24H,4-6,10-14H2,1-3H3/t16-,17+,19-/m1/s1^Y Key:GDFGTRDCCWFXTG-ZIFCJYIRSA-N^Y
^NY (what is this?) (verify)

Quinagolide: Difference between revisions

Latest revision as of 17:02, 20 August 2015

Overview

References

Navigation menu

Search